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Aortic Valve Disease in Turner Syndrome
Vandana Sachdev, MD,* Lea Ann Matura, RNP, PHD,† Stanislav Sidenko, BA,*
Vincent B. Ho, MD, MBA,‡ Andrew E. Arai, MD,* Douglas R. Rosing, MD,*
Carolyn A. Bondy, MD†
Bethesda, Maryland
Objectives Our goal was to determine the prevalence and characteristics of aortic valve disease in girls and women with
monosomy for the X chromosome, or Turner syndrome (TS).
Background Complications from congenital aortic valve disease are a major source of premature mortality in TS, but accu-
rate data on the prevalence of aortic valve abnormalities and their association with aortic root dilation are not
available.
Methods This prospective study characterized the aortic valve and proximal aorta in 253 individuals with TS age 7 to 67
years using transthoracic echocardiography as our primary screening tool, supplemented with magnetic reso-
nance imaging.
Results Transthoracic echocardiography revealed a normal tricuspid aortic valve (TAV) in 172 and a bicuspid aortic valve
(BAV) in 66 subjects. Transthoracic echocardiography could not visualize the aortic valve in 15 of 253 or 6%.
Magnetic resonance imaging diagnosed 12 of 15 of these cases (8 BAV and 4 TAV), so that only 3 of 253 (1.2%)
could not be visualized by either modality. The aortic valve was bicuspid in 74 of 250 (30%) adequately imaged
subjects. The prevalence was equal in pediatric (18 years, n  89) and adult populations. Over 95% of abnor-
mal aortic valves in TS resulted from fusion of the right and left coronary leaflets. Ascending aortic diameters
were significantly greater at the annulus, sinuses, sinotubular junction, and ascending aorta in the BAV group,
with aortic root dilation in 25% of subjects with BAV versus 5% of those with TAV.
Conclusions Girls and women with TS need focused screening of the aortic valve and root to identify the many asymptomatic
individuals with abnormal valvular structure and/or aortic root dilation. (J Am Coll Cardiol 2008;51:1904–9)
© 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.035d
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burner syndrome (TS) occurs in phenotypic female patients
issing all or part of 1 sex chromosome in all or most
omatic cells. It is the most common genetic disorder of
emale patients, affecting approximately 1 in 2,500 live
emale births (1,2). There is a broad phenotypic spectrum in
his syndrome, but almost all have short stature and early
varian failure (3,4).With current medical treatment includ-
ng growth hormone and estrogen, girls may attain near-
ormal adult stature and feminization. The major source of
remature mortality in TS is congenital cardiovascular
rom the *National Heart, Lung and Blood Institute, and †Developmental Endo-
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ational Institutes of Health, Bethesda, Maryland; and the ‡Departments of
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ervices University of the Health Sciences or the Department of Defense.v
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008, accepted February 5, 2008.isease, which is responsible for the demise of the great
ajority of TS fetuses by the second trimester (5,6).
linically severe defects, mainly aortic coarctation and/or
ortic valve disease, affect 10% of live-born girls with TS.
ransthoracic echocardiographic surveys of pediatric clinic
S patients in Europe suggest that congenital cardiovascu-
ar defects are found in 20% to 30% of young individuals,
ith bicuspid aortic valve (BAV) reported in 10% to
8% (7,8).
These studies did not focus on the aortic valve and did
ot provide morphologic detail of BAV structure or asso-
iated aortic diameters. Moreover, the actual prevalence of
AV in these studies remains uncertain because they did
ot report the number or percent of cases that could not be
scertained. Transthoracic echocardiography studies fo-
used solely on defining aortic valve structure report inabil-
ty to visualize or define aortic valve structure in 10% to 40%
f subjects, with particular difficulty defining BAVs (9,10).
dentifying a BAV in asymptomatic individuals is important
ecause they are at increased risk for infective endocarditis,
alve dysfunction, and for aortic aneurysm, which may
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May 13, 2008:1904–9 Aortic Valve Disease in TSequire intervention to prevent dissection or rupture. This
ssue is a major concern in TS, since the risk of aortic
issection is greatly increased (11–14).
The present study aimed to define the structure of the
ortic valve in a large group of girls and women with TS
articipating in a National Institutes of Health (NIH)
atural history study. The primary examination was trans-
horacic echocardiography focused specifically on the aortic
alve and ascending aorta. In cases where the valve was not
dequately visualized by echocardiography, cardiac magnetic
esonance imaging (MRI) studies were examined for aortic
alve morphology.
ethods
tudy subjects. Study participants were part of an ongoing
enotype-phenotype research study approved by the Na-
ional Institute of Child Health Institutional Review Board.
ll adult participants and parents of minors gave written
nformed consent, and minors gave written informed assent.
he study included bone mineral density, body composi-
ion, and metabolic function studies, as well as cardiovas-
ular assessment. Study subjects were recruited through
otices on the NIH web site and on the Turner Syndrome
ociety USA web site. There was no specific outreach to
eart patients or providers. Inclusion criteria were pheno-
ypic female subjects 7 years and older who had a 50-cell
eripheral karyotype with 70% of cells demonstrating loss
r partial loss of the second sex chromosome. One patient
ith a prosthetic aortic valve was excluded from the study.
wo other patients had endovascular valvuloplasty, and
hese were included. Neck webbing (pterygium colli) was
efined as redundant cervical skin folds arcing out from
astoid at ear lobe level to the acromium. The webbed neck
as a trapezoidal shape and is always associated with a very
ow posterior hairline and usually with low set, mal-rotated
ars, and down-sloping or hooded appearing eyes. All of
hese features are caused by the stretching of the developing
etal head and neck skin and scalp over the cystic hygromata.
chocardiography. Transthoracic 2-dimensional and
oppler echocardiography were obtained on all subjects
sing commercially available echocardiography machines.
he standard parasternal, apical, and subcostal views were
btained with the participants in the left lateral recumbent
osition. The images were stored digitally and on VHS
ideotape for analysis. Cardiac measurements were per-
ormed according to the American Society of Echocardiog-
aphy guidelines (15). Two authors (V.S. and S.S.) reviewed
ll studies for evaluation of the aortic valve morphology and
easurement of aortic diameters. Readers were blinded to
rior clinical history and results of other imaging studies.
he BAV was defined as partial or complete fusion of 2
usps, with or without a central raphe, resulting in partial or
omplete absence of a functional commissure between the
used leaflets (16). Abnormal aortic valves were further
lassified as “right-left” (fusion of right coronary and non- aoronary cusps) or “anterior-
osterior” (fusion of right and
eft coronary cusps) according to
revious studies (17). Supporting
eatures of abnormal valves in-
luded doming, thickening, or
edundancy of leaflets, eccentric
losure, or the presence of signif-
cant aortic regurgitation. Aortic
iameters were measured using a
eading-edge to leading-edge
echnique at end diastole and
ere averaged for 3 beats at each
ite. Measurements were taken at
he aortic annulus, sinuses of Valsalva, sinotubular junction,
nd 1 cm above the sinotubular junction. Some of the
ubjects in this study were reported in an earlier study
nvestigating the association between fetal lymphedema and
ongenital heart defects in TS (18). However, all echocar-
iography studies were reread by expert echocardiographers
V.S. and S.S.) with additional measurements of aortic
iameters for the present study.
RI. Study subjects routinely had cardiac MRI as well as
chocardiography. The thoracic vascular anomalies of the
nitial study cohort have previously been reported (19).
agnetic resonance imaging included cine MRI, black
lood imaging, and velocity-encoded cine phase contrast
ulse sequences. Magnetic resonance imaging studies were
sed as a secondary diagnostic modality when the echocar-
iography reading was uncertain or the aortic valve was not
dequately visualized. Magnetic resonance interpretations
ere provided by Drs. Ho and Arai.
tatistical analysis. Data for continuous variables are
hown as means  standard error and are compared by
nalysis of variance or analysis of covariance adjusted for age
nd body surface area (BSA) followed by t test. Nominal
ata are presented as proportions and compared by chi-
quare tests. Linear regressions analyzed the correlation
etween ascending aortic diameter determined by MRI
ersus echocardiography. Statistical significance was a
value0.05. Analyses were performed using Stat View for
indows, version 5.0.1 (SAS Institute Inc., Cary, North
arolina).
esults
he study included 253 consecutive study subjects that
nderwent transthoracic echocardiography. Participants
anged in age from 7 to 67 years, with 89 subjects18 years
ld. Twenty-five study subjects had had surgical repair of
ortic coarctation during childhood. Transthoracic echocar-
iography assigned aortic valve diagnoses as follows: 164
ricuspid aortic valve (TAV), 8 probable TAV, 63 BAV, 3
robable BAV, and 15 nonvisualized. One-third of these
AVs had no visible raphe, and two-thirds were function-
Abbreviations
and Acronyms
BAV  bicuspid aortic
valve
BSA  body surface area
MRI  magnetic resonance
imaging
NIH  National Institutes
of Health
TAV  tricuspid aortic
valve
TS  Turner syndromelly bicuspid with partial or complete fusion of 2 aortic valve
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Aortic Valve Disease in TS May 13, 2008:1904–9eaflets along a raphe. Bicuspid valves had “anterior-
osterior” configuration (fusion of right and left coronary
usps) in the great majority of patients (63 of 66). There was
o significant difference in age, weight, or BSA that might
xplain the difficulty imaging the aortic valve in the group
esignated as nonvisualized by echocardiography.
For the 26 cases where aortic valves were not well
isualized by echocardiography, MRI was used as a supple-
entary approach. Magnetic resonance imaging was able to
etermine valve structure in 12 of 15 cases not visualized on
chocardiography; of these, 8 were BAV and 4 TAV.
oreover, MRI confirmed a TAV in all 8 “probable” cases
nd confirmed BAV in two-thirds of the probable cases.
he third case was too poorly visualized on MRI to
etermine valve structure. Based on the high predictive
alue of the “probable” echocardiographic diagnosis in the
ther cases, we accepted the third case as BAV in subse-
uent calculations. Thus, in total, echocardiography supple-
ented with MRI identified 176 of 253 subjects (70%) with
normal TAV and 74 of 253 (29%) with BAV, and only 3
ases remained undetermined (1%).
Table 1 summarizes characteristics of the groups with
AV versus TAV. They were similar in age and body size.
he prevalence of BAV in those 18 years of age was 28 of
9, or 31.5%, with 1 case undetermined. This indicates, on
he one hand, that that there is no bias toward detecting
AV in small girls, and on the other hand, there does not
eem to be any prominent increase in prevalence of abnor-
al valve structure over time in these patients.
As expected, peak flow through the aortic valve was
reater in the BAV group, as were aortic diameters
Table 1). Aortic regurgitation was trivial or less in 55%,
ild in 30%, and moderate or severe in 15%. Aortic
eatures Associated With TAVrs s BAV in Girls and Women With TS
Table 1 Features Associated With TAVVersus BAV in Girls and Women With TS
TAV (n  176) BAV (n  74) p Value
Age (yrs) 28.8 15.2 26.6 14.0 0.22
Height (cm) 143.6 11.1 143.3 12.3 0.87
BSA kg/m2 1.44 0.3 1.42 0.3 0.58
Sys BP (mm Hg) 115 11 114 12 0.9*
Dias BP 69 9 70 9 0.4*
HR (beats/min) 86 11 88 11 0.4*
Peak flow (m/s) 1.30 0.21 1.62 0.66 0.0001*
Annulus (cm) 1.88 0.35 2.07 0.49 0.001*
Sinuses (cm) 2.61 0.39 2.80 0.49 0.003*
Sinotubular junction (cm) 2.11 0.35 2.31 0.46 0.001*
Ascending aorta (cm) 2.34 0.38 2.62 0.63 0.0005*
Dilated aorta† 9/169 (5.3%) 17/69 (25%) 0.002
Neck webbing 43/176 (24%) 33/74 (45%) 0.003
Aortic coarctation 9/176 (5%) 16/74 (22%) 0.002
ata for continuous variables are means  standard error and are compared by analysis of
ariance or *analysis of covariance adjusted for age and body surface area (BSA) followed by t test.
ominal data are presented as proportions and compared by chi-square tests. †Measurements of
ortic diameter at the sinuses were available for 246 subjects, 8 of whom were too small for the
oman nomograms.l
BAV  bicuspid aortic valve; Dias BP  diastolic blood pressure; HR  heart rate; Sys BP 
ystolic blood pressure; TAV  tricuspid aortic valve; TS  Turner syndrome.tenosis was uncommon. Only 2 study subjects had a peak
ortic flow velocity of 3 m/s or greater. One woman had
velocity of 3 m/s associated with a BAV and moderate-
o-severe aortic regurgitation. She had undergone an
ndovascular valvuloplasty as a child. The second woman
ad a BAV with a peak velocity of 5.5 m/s, and had
ndergone valvuloplasty in recent years with little im-
rovement. Aortic diameters were greater at all points in
he BAV versus TAV group (Fig. 1A). Diameters at the
inuses of Valsalva and the sinotubular junction were
lotted against BSA on Roman nomograms (20) to
dentify subjects with dilation of the aortic root. Mea-
ured at the sinuses, 25% of the BAV group and 5% of the
AV group had aortic dilation (Table 1). The results for
easurements at the sinotubular junction were similar
data not shown).
orrelation between echocardiographic and MRI mea-
urement of ascending aortic diameter. Aortic diameter
easurements were systematically acquired by MRI at the
evel of the right pulmonary artery origin, which is typically
1.5 cm above the sinotubular junction measurement made
y echocardiography. Simple regression showed a close
orrelation between the 2 measurements (Fig. 1B).
henotypic and genotypic correlations. There was a
ighly significant association between the presence of
eck webbing and BAV, and similarly between aortic
oarctation and BAV (Table 1). The table shows that a
ebbed neck is significantly more common in patients
ith BAV. To look at it another, more clinically relevant
ay, almost 50% of TS patients with neck webbing have
ongenital cardiovascular defects. Approximately 31% of
ur group of 250 study subjects had neck webbing; of
hese, 45% had BAV and/or aortic coarctation, whereas
nly 23% of the nonweb group had these defects. The
ajority (63%) of study subjects had a pure TS karyo-
ype of 45,X. The 46,XiXq group (IsoQ) have the second
chromosome missing the short arm (Xp) with 2 copies
f the long arm fused together. Finally, there were small
roups in which the second X chromosome was missing
ust the short arm (46,XdelXp; Pdel) or the long arm
46,XdelXq; Qdel). The prevalence of BAV in the
ifferent karyotype groups is shown in Table 2. Unfor-
unately, the most informative groups missing just a short
r just a long arm are very small, and thus, statistical
onclusions are limited. One may argue, however, that
hese data are more consistent with a locus on the short
rm, Xp. This is because there is a significant increase in
AV in the groups lacking only the Xp, that is, the Pdel
nd IsoQ. Subjects in these karyotype groups are missing
ost or all of Xp but have retained the Xq (in the Pdel)
r have an additional copy Xq (in the IsoQ group). Thus,
hey are monosomic for Xp only. Although the numbers
re small, the BAV prevalence in these groups is still at
east 10-fold higher than in the 46,XX population (21).
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May 13, 2008:1904–9 Aortic Valve Disease in TSiscussion
n the present study we have shown that 30% of asymp-
omatic, unselected female subjects with TS have BAVs,
lmost all resulting from fusion of the right and left
oronary leaflets. Previous echocardiographic screening
tudies have reported a prevalence of BAV in TS ranging
rom 10% to 18.5% (7,8,22–24). There are a few potential
xplanations for a lower discovery rate in the previous
tudies. The earlier studies were not particularly focused on
he aortic valve and did not describe how many cases were
ot adequately visualized. Nor did they report on valve
tructure (i.e., leaflet fusion), function, or any association
etween abnormal aortic valve and aortic root dilation.
ransthoracic echocardiography has difficulty in visualizing
he aortic valve in 10% to 40% of subjects, especially those
ith BAVs (9,10). In the present, highly focused study,
ortic valves were poorly visualized in 5% and nonvisual-
Figure 1 Effect of AV Morphology on
Ascending Aortic Diameters in Turner Syndrome
(A) Measurements were at the annulus, midpoint of the sinuses of Valsalva,
sinotubular junction (STJ), and ascending aorta (Asc) 1 cm above the STJ. The
box includes the 25th to 75th percentiles and whiskers include the 10th to
90th percentiles. The horizontal line in the box indicates the median, and all
observations less than the 10th and greater than the 90th percentiles are
shown as points. (B) Correlation between Asc diameter measured by echocar-
diography (Echo AD) and magnetic resonance imaging (MR AD). The echocardi-
ography measurement was 1 cm above the STJ, and the magnetic resonance
imaging measurement was at the level of the right pulmonary artery. The dis-
tance between these 2 points is 5 to 10 mm. BAV  bicuspid aortic valve; TAV
 tricuspid aortic valve.zed in 6% of subjects. However, with cardiac MRI evalu-
stion of those not well seen on echocardiograms, we were
ble to determine aortic valve structure in almost 99% of
tudy subjects. Interestingly, consistent with prior studies,
e found the majority of aortic valves not captured by
chocardiography to be abnormal. Thus, if early TS studies
ad a large proportion of inadequately imaged cases, there
ay have been a bias toward reporting normal valves.
nother important difference is that in contrast to the NIH
tudy, the previous studies included patients with high-
rade mosaicism for normal cells. These patients are typi-
ally less expressive of most phenotypic features of the
yndrome, so there may have been a true lower prevalence
f BAV.
Selection bias is a potential concern in any prevalence
tudy. Recruitment to this TS study reflects the current
lectronic age in that approximately one-half of the partic-
pants found the study by searching the web; the second
argest group of individuals heard about the study by word
f mouth from other participants or at TS support group
eetings. Only about 10% came through medical referrals,
nd none of these were specifically related to cardiac
oncerns. Most of the adults received care from family
ractitioners or gynecologists, and about one-third had
ever had any previous cardiac evaluation (25). So it seems
nlikely that we had any particular bias toward cardiac
atients in this study. The prevalence of BAV determined in
he present study pertains to TS individuals that have
urvived to age 7 years and older. The prevalence of aortic
alve abnormalities and other congenital defects appears to
e much higher in TS fetuses, with the great majority dying
n utero due to circulatory failure (6,26,27). About 10% of
ewborns with TS have very serious cardiovascular defects,
ainly hypoplastic left heart, and survival is poor (24).
ence, this and other studies evaluating the cardiovascular
ystem in girls and adults with TS are seeing the survivors,
n whom BAV is often an isolated defect that may not be
linically detected except by focused screening.
We have shown that the great majority (95.5%) of
bnormal aortic valves in TS result from fusion of right
nd left coronary leaflets. This is somewhat different than
n larger BAV populations, in which only 60% to 70%
how fusion of coronary leaflets (28 –30). This particular
alve anatomy was highly associated with left-sided
ongenital defects (30). In a smaller previous study, we
emonstrated a strong association between the presence
enotype and BAV Prevalence
Table 2 Genotype and BAV Prevalence
BAV TAV Totals
45,X 57 (36%) 101 158
IsoQ 5 (22%) 18 23
Pdel 1 (9%) 10 11
Qdel 0 4 4
or the sake of clarity, individuals with karyotypes including high-grade mosaicism (i.e., major
ontributions from 2 or more cell lines) were excluded from this comparison. See the Results
ection for further explanation of these karyotypes.
IsoQ  46,XiXq; Pdel  46,XdelXp; Qdel  46,XdelXq; other abbreviations as in Table 1.
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Aortic Valve Disease in TS May 13, 2008:1904–9f neck webbing—the residua of central fetal lymphede-
a—and cardiovascular defects including BAV and aor-
ic coarctation in TS (18). We have confirmed the
ssociation in the present much larger study. This asso-
iation was first noted in spontaneously aborted fetuses
ith TS that had large cystic hygromas (31). The nuchal
ystic hygromas are collections of lymph associated with
lind-ended jugular lymphatics (26,27,31,32). In fetuses
hat survive, the lymphatics develop and hygromas re-
olve during the latter half of gestation, leaving redun-
ant skin folds of the neck. Clark (31) suggested that
entrally localized distended lymphatics compress the
eveloping aortic root, resulting in specific left-sided
efects, including hypoplastic left heart, BAV, and co-
rctation due to low flow, and specific right-sided defects
uch as persistent left superior vena cava, anomalous pulmonary
enous return, and dilated right atrium, due to back pressure
rom obstruction to forward flow. The present study show-
ng a pattern of anterior-posterior fusion of aortic leaflets
eems consistent with predominantly left-sided outflow
ract defects characteristic of TS.
An alternative explanation for the association between
eck webbing and BAV in TS could be that haploinsuf-
ciency for an X-chromosome gene causes central fetal
ymphedema and aortic heart defects independent of each
ther. Haploinsufficiency for an autosomal gene (FOXC2;
6q) causes lymphedema and occasional cardiac defects in
he Lymphedema-Distichiasis syndrome (33). However,
argeted deletion of this gene in mice results in abnormal
ortic arch development without lymphedema (34), sug-
esting that the heart defects and lymphedema may be
ndependent effects of haploinsufficiency for FOXC2.
hus, it is possible that biallelic expression of 1 or more
seudoautosomal genes located on both X and Y chro-
osomes is essential for normal cardiovascular develop-
ent in both genders. There are at least 20 such genes or
utative genes that are expressed from both sex chromo-
omes and do not undergo inactivation on the supposedly
nactive X. Thus far, we know the function of just 1 of
hese genes, SHOX, which is required in 2 copies for
ormal skeletal development and longitudinal bone
rowth (35). Haploinsufficiency for SHOX results in
20 cm shortfall from the genetically predicted adult
eight, while an extra copy, as in Klinefelter syndrome
47,XXY), results in taller then expected stature. Most
seudoautosomal genes are located on Xp, consistent with
ur observations that the BAV phenotype is associated with
osomy for Xp specifically.
Bicuspid aortic valve is found in 1% to 2% of the general
opulation, with a 2-fold higher prevalence in male versus
emale patients (21). Given the male predominance, one
ight expect an X-linked contribution to risk, and consis-
ent with this view, mutations in the filamin A (FLNA) gene
ave been implicated in myxomatous cardiac valve disease
36). However, the cardiac phenotype in myxomatous val- fular dystrophy (OMIM 314400) is very different than in
S. There are other X-linked genes that might be impli-
ated in cardiovascular development (e.g., the genes encod-
ng VEGF-D and the angiotensin type 2 receptor, both of
hich have roles in fetal development). However, if the
ncreased prevalence of BAV in TS were due to exposure of
recessive mutation in FLNA or another X-linked gene,
ne would expect a frequency of a few percent, as seen in the
ale population, not 30%, as we have demonstrated among
irls and women with TS.
We found that ascending aortic dilation, defined as aortic
iameter greater than the 95th percentile for BSA, was
resent in 25% of BAV and 5% of TAV subjects with TS,
t both the sinuses of Valsalva and sinotubular junction.
scending aortic dilation has been reported in 10% to 40%
f girls and women with TS (11,37–40), but these previous
tudies did not differentiate between those with BAV versus
AVs. The presence of a BAV is associated with aortic
ilation in the general population, irrespective of valve
unctional status (41–43). For example, in the most recent
tudy cited, the prevalence of aortic root dilation was 16% at
he sinuses of Valsalva and 18% at the sinotubular junction
or a group of adults with isolated BAV with a mean age of
4 years (43). The association between abnormal aortic
alve anatomy and proximal aortic abnormalities including
oarctation and dilation has shaped the view of a common
nderlying developmental defect involving the aortic valve
nd the wall of the ascending aorta. The present observa-
ions suggest this may be true in TS as well as in nonsyn-
romic BAV.
The diagnosis of BAV is predominantly determined by
chocardiography, which is, according to our observations,
uite sensitive (66 of 74  89%). Clinicians must insist on
lear visualization of the aortic valve and root, and if not
ccomplished by echocardiography, then MRI should be
he next approach. Expertise in cardiac MRI is not so
idespread at present, and referral to a tertiary center may
e necessary to obtain optimal visualization of the aortic
alve (44). Transesophageal echocardiography is an alterna-
ive approach (10).
onclusions
n summary, this study of a very large group of asymptom-
tic, unselected girls and women with TS has uncovered an
xtraordinarily high prevalence of BAV, which is clearly
ssociated with aortic root dilation. Even though there is no
ffective treatment at present, close medical follow-up is
ssential to prevent complications such as endocarditis,
ortic dilation and dissection, and to evaluate the severity of
he valvular defects and determine when intervention is
equired. Given the high mortality rate of these complica-
ions (13), all patients with TS should undergo careful
chocardiographic evaluation for early identification and
ollow-up of aortic valve and root abnormalities.
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